A study by Campbell et al. (2013) using principal component analysis provided evidence that APOE4 status did not affect amyloid-beta burden (assessed via mean [11C]-PiB binding) in 13 PD subjects experiencing cognitive impairment (Campbell et al., 2013). The gene discussed is APOE; the disease is Parkinson disease.